Sign Up
OverviewAPI
The global diabetic retinology market is projected to reach USD 13.23 billion by 2031, driven by factors such as the increasing prevalence of diabetes and advancements in diagnostic technologies. Major vendors include Bayer, Abbvie, Novartis, EYESONIC, and more. The North American market is expected to dominate, with Diabetic Macular Edema (DME) holding the largest market share.

Ask a question